Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
KMDA
IL0010941198
Pharmaceuticals
Sales 2024 * | 587M 158M 12.61B | Sales 2025 * | 664M 179M 14.26B | Capitalization | 1.2B 322M 25.71B |
---|---|---|---|---|---|
Net income 2024 * | 55M 14.8M 1.18B | Net income 2025 * | 66M 17.76M 1.42B | EV / Sales 2024 * | 2.04 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.25% |
Latest transcript on Kamada Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 08/12/13 |
David Tsur
FOU | Founder | 73 | 12/12/90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 30/12/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 23/12/19 |
Leon Recanati
BRD | Director/Board Member | 76 | 30/04/05 |
David Tsur
FOU | Founder | 73 | 12/12/90 |
1st Jan change | Capi. | |
---|---|---|
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |